Wegovy 1.7mg FlexTouch

Wegovy 1.7mg FlexTouch is used for cardiovascular risk reduction and weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have at least one related health condition. It works best when combined with a balanced diet and regular physical activity.

Additionally, it is used for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults.

Wegovy 1.7mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Wegovy 1.7mg FlexTouch include nausea, vomiting, diarrhea, and constipation. These are usually mild to moderate and tend to improve as the body adjusts to treatment. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 1.7mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 1.7mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

• Risk Reduction of Heart disease
• Management of Obesity
• Treatment of Metabolic dysfunction-associated steatohepatitis (MASH)

Wegovy 1.7mg FlexTouch comes in a prefilled pen designed for self-administration and is convenient to use. However, speak with your doctor or healthcare provider for proper training, either for you or your caregiver, to ensure safe and effective use at home.